[Current treatment of testicular cancers].
The treatment and prognosis of dysembryoma of the testis have been transformed by the dissection of retroperitoneal nodes and by combination chemotherapy as early as possible. Routine retroperitoneal node dissection followed by early and prolonged chemotherapy lead to a hope of cure in more than 75% of cases of dysembryoma of the testis. Similar early chemotherapy is effective and indicate for choriocarcinoma of the testis and retroperitoneal node dissection may be of value in tumours in which the chorial element is "minor".
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002369:Castration; D002822:Choriocarcinoma / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D008722:Methods; D009362:Neoplasm Metastasis; D011379:Prognosis; D012075:Remission, Spontaneous; D012187:Retroperitoneal Space; D013724:Teratoma / Q000628:therapy*; D013736:Testicular Neoplasms / Q000628:therapy*
D000970:Antineoplastic Agents
Les traitements actuels des cancers du testicule